We are live on ! Find out more

Bushido Capital US Equity ETF

SMRI

Market cap $711M

47.31 USD

-0.38

0.8%

At close Updated Nov 12, 4:00 PM EST

1 day

-0.8%

5 days

1.74%

1 month

2.71%

3 months

1.05%

6 months

21.65%

Year to date

30.91%

1 year

32.78%

5 years

87.14%

10 years

87.14%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 100%

Neutral 0%

Negative 0%

SMRI: Stellar YTD Performance And Quality Exposures, Yet Nuances Exist, A Hold

I initiate coverage of the Bushido Capital US Equity ETF with a Hold rating. SMRI's portfolio boasts a robust GARP and quality factor mix, with a weighted average PEG ratio of 0.75 and a 5.4% earnings yield, as per my calculations. Despite a YTD return of over 34%, the fund lacks performance consistency: before 2026, its returns were drab, with two consecutive calendar years of underperformance versus the IVV.

SMRI: Stellar YTD Performance And Quality Exposures, Yet Nuances Exist, A Hold

SMRI: Don't Jump The Gun Based On The Fed's Interest Rate Decision Today

The Bushido Capital US Equity ETF is currently too expensive and not well-positioned for a potential economic downturn, especially given its low allocation to resilient sectors like consumer staples and utilities. SMRI is heavily weighted towards healthcare and consumer cyclical sectors, which may benefit from falling interest rates, but it's too early to rotate into value stocks. The Fed's interest rate cuts are uncertain and may not lead to rapid declines, making it premature to invest in this ETF for short-term gains.

SMRI: Don't Jump The Gun Based On The Fed's Interest Rate Decision Today

CNBC Television

The return of value investing ETFs

CNBC's Bob Pisani sits down with KraneShares chief investment officer Brendan Ahern and Sepio Capital co-CIO and managing director John Beatson to discuss the rise of value investing ETFs and the philosophy behind Sepio Capital's strategy.

See News Rankings

Price charts implemented using Lightweight Charts™